Michael Varney
Senior Vice President, Research Administration
"I like football more than I like tennis."
- 8
years at Genentech
I joined Genentech in June of 2005 as vice president, Small Molecule Drug Discovery. In this role I am responsible for all aspects of the small molecule discovery effort, which includes Medicinal chemistry, DMPK, Computational Chemistry, Analytical Chemistry, Assay Development, High Throughput Screening, Formulation, Analytical Development, and Small Molecule scale-up and process chemistry.
I was attracted to Genentech because of my long-standing interest in translating excellent science into therapies to treat unmet medical needs. I am excited by the prospect of utilizing Genentech's deep expertise in biology to discover and develop small molecule drugs that are innovative and contribute to the health and well-being of our community. I have always been attracted to the idea of building large diverse teams of scientists who work together to solve very difficult problems. I like to build.
Featured Publication
Biological properties of AG2037: a new inhibitor of glycinamide ribonucleotide formyltransferase with low affinity for the folate receptor
Proc Am Assoc Cancer Res 40(90); 291-92
Bartlett, C. A., Boritzki, T. J., Dagostino, E. F., Margosiak, S. A., Palmer, C. L., Romines, W. H., Varney, M. D
